Antibiotics save babies’ lives. Parents and pediatricians know this.

What nobody tracked closely, until now, was what antibiotics do to the fungi living in a baby’s gut – and whether those fungi were already shaping children’s immune futures long before the first prescription.


EarthSnap

Two new studies suggest the answer to both questions is yes.

The forgotten gut tenants

Scientists have spent nearly two decades mapping the gut’s bacteria, the community we call the microbiome.

The gut fungi got left behind. That fungal population has its own name, the mycobiome, yet barely anyone has asked what it does to us.

The tiny share of fungi in the gut made them easy to dismiss. Earlier work only loosely linked infant gut fungi to later trouble – such as one study of children at risk of autoimmune disease.

Yet fungal cells are larger than bacteria and press directly against the gut lining, so even a sparse population can count.

Two Canadian teams set out to bring the fungi into focus. One tracked them inside hundreds of healthy babies. The other tested what antibiotics do to them. Their papers came out together.

A fungal growth chart

The first team, led by Dr. Stuart Turvey, a childhood immunity researcher at BC Children’s Hospital Research Institute (BCCHR) in Vancouver, drew on a Canadian project following thousands of children from birth.

The researchers analyzed more than 2,200 stool samples from over 1,400 infants.

As the babies grew, their gut fungi changed on a surprisingly orderly schedule. Over the first year, yeasts related to baker’s and brewer’s yeast (Saccharomyces) climbed about 14-fold.

Meanwhile Malassezia – a yeast best known for living on skin and causing dandruff – dropped nearly 50-fold. That a skin fungus turns up deep in the gut surprised the team.

The pattern was so reliable that the researchers could estimate a baby’s age from its fungi alone, closely matching reality. No one had charted infant gut fungi at this scale before.

Falling behind schedule

Some babies lagged on this fungal timetable, their one-year guts still resembling a three-month-old’s.

Turvey’s team had already shown that slow-developing gut bacteria raise allergy risk, in an earlier study. Now the fungi told a matching story.

By age five, eczema – which doctors call atopic dermatitis – appeared in about 22% of children whose fungi matured slowly, against roughly 15% of those on track. Food allergies followed the same pattern.

Tellingly, the delay flagged only eczema and food allergy, not asthma or hay fever – conditions that begin where the body meets the world, at the skin and gut lining. The study showed a link, not that the fungi caused it.

Antibiotics tip the balance

Dr. Marie-Claire Arrieta, a microbiologist at the University of Calgary (UCalgary), studied 47 babies under six months who came to a hospital emergency department and were prescribed antibiotics.

Her team sampled each infant’s gut before and after treatment.

The antibiotics did exactly what they were meant to do – knocking back the bacteria. The fungi responded by expanding.

One yeast surged above the rest – Malassezia again.

Bacteria normally compete with fungi for space and resources in the gut, so clearing them out may allow the yeast to expand – though the precise mechanism behind that shift remains unclear.

“Antibiotics are an essential treatment for young children when needed,” said Arrieta.

But the drugs carry an overlooked side effect that lets Malassezia flourish. A link in 47 babies, though, cannot prove harm.

Testing gut fungi in mice

To test the cause, Arrieta’s group turned to mice.

In their companion paper, they raised the animals in a sterile environment – with no microbes at all – then gave some only a fixed set of gut bacteria and others that set plus one Malassezia species (M. restricta).

Adding the yeast alone tipped the young mice’s immune systems off balance.

Their guts and lymph nodes filled with allergy-linked immune cells, among them eosinophils – the cells that spike during allergic reactions. The fungus was steering how their defenses developed.

The real test came in the lungs. Exposed to house dust mite, an everyday allergy trigger, mice carrying Malassezia developed far worse airway inflammation – swollen, damaged lung tissue – than those without it.

Stripping out the eosinophils dialed much of the reaction back, pinning part of the damage on those cells. For the first time, a single gut yeast had been shown to drive allergic airway disease.

What this could change

Two threads now meet. A baby’s gut fungi follow a predictable course, and lagging behind it tracks with eczema and food allergy.

Antibiotics can knock that course off track by letting Malassezia bloom, which in mice drives allergic disease.

That opens practical doors. The fungal cost gives doctors another reason to avoid needless antibiotics in a baby’s first months.

Treatments that nudge the mycobiome back on schedule, or curb Malassezia, become a plausible path toward preventing allergies early – something the field could not seriously investigate before these studies existed.

Allergic disease affects hundreds of millions of children, and the numbers keep climbing.

Understanding and preventing these conditions “would have an enormous benefit for children around the globe,” said Turvey. The overlooked fungi may be where some answers were hiding.

The study is published in the journal Nature Communications.

—–
Like what you read? Subscribe to our newsletter for engaging articles, exclusive content, and the latest updates.

Check us out on EarthSnap, a free app brought to you by Eric Ralls and Earth.com.
—–